Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
260
-
Total 13F shares, excl. options
-
128M
-
Shares change
-
-1.13M
-
Total reported value, excl. options
-
$3.62B
-
Value change
-
+$9.64M
-
Put/Call ratio
-
1.21
-
Number of buys
-
124
-
Number of sells
-
-128
-
Price
-
$28.28
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q3 2024
328 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q3 2024.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 260 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 128M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (12.6M shares), VANGUARD GROUP INC (10.9M shares), BlackRock, Inc. (8.8M shares), RA CAPITAL MANAGEMENT, L.P. (8.51M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (4.94M shares), FMR LLC (4.33M shares), JPMORGAN CHASE & CO (4.12M shares), Engaged Capital LLC (3.99M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.8M shares), and Granahan Investment Management, LLC (3.49M shares).
This table shows the top 260 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.